Correlation Between INTEL CDR and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both INTEL CDR and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INTEL CDR and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between INTEL CDR and Helix BioPharma Corp, you can compare the effects of market volatilities on INTEL CDR and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INTEL CDR with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of INTEL CDR and Helix BioPharma.

Diversification Opportunities for INTEL CDR and Helix BioPharma

-0.35

Correlation Coefficient

INTEL CDR  Helix BioPharma

Very good diversification

The 3 months correlation between INTEL and Helix is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding INTEL CDR and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and INTEL CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INTEL CDR are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of INTEL CDR i.e., INTEL CDR and Helix BioPharma go up and down completely randomly.

Pair Corralation between INTEL CDR and Helix BioPharma

Assuming the 90 days trading horizon INTEL CDR is expected to under-perform the Helix BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, INTEL CDR is 1.91 times less risky than Helix BioPharma. The stock trades about -0.09 of its potential returns per unit of risk. The Helix BioPharma Corp is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  87.00  in Helix BioPharma Corp on October 9, 2024 and sell it today you would earn a total of  6.00  from holding Helix BioPharma Corp or generate 6.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

INTEL CDR  vs.  Helix BioPharma Corp

INTEL CDR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days INTEL CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Helix BioPharma Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Helix BioPharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Helix BioPharma is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with INTEL CDR and Helix BioPharma

The main advantage of trading using opposite INTEL CDR and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INTEL CDR position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind INTEL CDR and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.